Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -3.49% | +1.35% | -84.71% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.98M |
---|---|---|---|---|---|
Net income 2024 * | -5M | Net income 2025 * | -10M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.27
x | P/E ratio 2025 * |
-0.55
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 24.32% |
Latest transcript on Quoin Pharmaceuticals, Ltd.
1 day | -3.49% | ||
1 week | +1.35% | ||
Current month | -3.49% | ||
1 month | -3.39% | ||
3 months | -72.93% | ||
6 months | -86.11% | ||
Current year | -84.71% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Myers
CEO | Chief Executive Officer | 62 | 18-03-04 |
Denise Carter
FOU | Founder | 55 | 18-03-04 |
Gordon Dunn
DFI | Director of Finance/CFO | 60 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Sember
BRD | Director/Board Member | - | 21-10-27 |
Dennis Langer
BRD | Director/Board Member | 73 | 21-10-27 |
Joseph Cooper
BRD | Director/Board Member | 66 | 21-10-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 0.75 | -3.49% | 22,409 |
24-05-31 | 0.7771 | +10.86% | 39,988 |
24-05-30 | 0.701 | +0.14% | 26,658 |
24-05-29 | 0.7 | -2.78% | 66,882 |
Delayed Quote Nasdaq, June 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.71% | 2.98M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+37.07% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- QNRX Stock